# ExoLuminate Study for Early Detection of Pancreatic Cancer

> **NCT05625529** · — · RECRUITING · sponsor: **Biological Dynamics** · enrollment: 1000 (estimated)

## Conditions studied

- Pancreas Cancer
- Exosomes
- Extracellular Vesicles
- Pancreatic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05625529
- **Lead sponsor:** Biological Dynamics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-19
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625529, "ExoLuminate Study for Early Detection of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05625529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*